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Lung tumors are the most important group of cancers and are the leading cause of cancer-related patient deaths worldwide (0.9 million population) [1] . Pulmonary tumors can be classified as primary or metastatic; however, small-cell lung carcinoma and non-small-cell lung carcinoma are classifications for primary lung tumors [2] . Normally, carcinogenic lung lesions are treated using surgery, radio-oncological methods, systemic chemotherapy or immune therapy. In addition to these methods, interventional radiology offers many new techniques such as radiofrequency ablation (RFA), microwave ablation and laser-induced thermotherapy (LITT) in order to treat lung lesions. These interventional techniques can be used for the treatment of lung tumors that are ≤3 cm in diameter and have ≤3 lesions in number; furthermore, these techniques provide local tumor control rates of more than 85%.
Planning & treatment
The relevance of ablation therapy, patient age and medical history should be considered for all patients before examination. Interventionalists should make a proper assessment of the scope and risks of the procedure before treatment. Patients' respiratory and physiological restrictions should be evaluated. Lung function analysis, respiratory flow measurement using spirometry and forced expiratory volume in 1 s measurements must be performed before the examination. Furthermore, lung perfusion, arterial blood gas evaluation and spiroergometry are required before the LITT procedure. Patient contraindications for the LITT procedure are: bleeding coagulopathy based on international normalized ratio >1.8; and platelet count <50,000/dl.
A number of small applicators are placed directly in the tumor using minimally invasive percutaneous puncture (Figures 5.1 & 5.2) [3] . The interventional procedure is usually performed under computed tomography (CT) guidance in contrast to MRI. CT imaging provides excellent contrast between tumor and lung parenchyma. It also ensures adequate estimation of the achieved coagulated volumes. In MRI, it is more difficult to detect pneumothorax or probe dislocation. Clinical problems associated with LITT therapy include pneumothorax and treatment probe dislocation; hence, MRI is not commonly suggested as a realtime imaging modality for the regular LITT procedure. Sufficient differentiation among
Due to the comparably high penetrability of photons and the possibility of complicationfree transfer of energy through guide light, a neodymium-doped yttrium aluminum garnet laser (1064 nm) is mostly used for laser-induced thermotherapy (LITT). The energy is applied to the target tissue using special laser applicators. The energy of laser light is absorbed, which causes coagulation of tumor as well as surrounding normal tissue.
The puncture needle will be positioned under computed tomography control af ter disinfec tion of skin and regional analgesia. www.futuremedicine.com lung parenchyma and tumor can be obtained using CT imaging data, and an adequate assessment of coagulation volume after LITT treatment can be ensured (Figure 5.3) . Usually, the LITT treatment procedure is easier to perform in more central lung lesions compared with peripheral lesions. There is always the risk of pneumothorax during or after the procedure; proper precautions should be taken by the procedural personnel to prevent pneumothorax during needle puncture.
LITT treatment allows us to minimize damage to healthy lung tissues (around the involved area) and to destroy all suspected malignant cells inside the target tissue volume. As a result, maximum healthy lung tissues are preserved so that the vital functions of the organ can still be performed. Compared with surgery, LITT treatment offers the possibilities of repeated treatment options (repeated surgical procedures are usually difficult), follow-up suitability using MRI and improved quality of life [4] . In addition, there is also a cost benefit in comparison with other treatment options [5] . Treatment using LITT is difficult if the lesions are located in the areas of the lung that are difficult to access (e.g., behind the rib). In this situation, precise positioning of the applicator system is not possible using direct puncture, which is a disadvantage of the technique. During treatment, carbonization of the normal tissue is undesirable; normal lung parenchyma should always be preserved [3, [6] [7] [8] .
Complications of pulmonary LITT
Pulmonary ablation therapy has been considered as a safe and minimally invasive method compared with surgery, but associated procedure-related complications have to be expected. Complications may include pneumothorax, intraparenchymal hemorrhage, intrapleural hemorrhage, pleural effusion, tumor seeding and thermal damage to healthy tissue. Some common minor side effects, such as pain in the area of the puncture site, pleuritic pain, nausea, vomiting, moderate fever, fatigue and headache, are also quite frequent. The treatment effectiveness usually depends on the work experience of the interventionalist and team members, as well as the duration or amount of energy used for the treatment. The desired temperature for normal LITT is approximately 50-55°C. Protein denaturation takes place within a few seconds for temperatures exceeding 60°C [101] . It is necessary to control the complete procedure using real-time monitoring methods such as CT image guidance in order to achieve the desired result.
Results
We reviewed seven articles published from 2003 to 2012, which include 86 patients and 65 specimens obtained directly from the lungs of the patients (Table 5 .1). The number of patients in these articles varied from 10 to 48, and the treatment of choice was LITT. Primary or metastatic pulmonary tumors were the pathologies involved in these articles. The reported overall treatment outcome was good in all articles and no major complications were reported in these studies. Hoffmann et al. assessed the effect of temperature on tissue coagulation during laser ablation using the ex vivo lung tumor model [9] . The authors concluded that applied temperature during LITT has a direct effect on pulmonary tumor coagulation. Koch et al. also used the ex vivo model and compared temperature diffusion using one and two treatment applicators during thermal ablation [10] . The authors found that there was a significant increase in the achieved temperature in the tissues using two laser applicators.
Hegenscheid et al. analyzed induced early vascular changes in treated lung tumors followed by LITT and predicted the technical success rate of the therapy using LITT with CT perfusion [11] . The authors concluded that CT perfusion after LITT showed vascular changes and this technique was useful for evaluating the success rate of the therapy. Vogl et al. performed a comparative study with 20 patients using LITT and RFA [12] . The authors concluded that both therapies were safe and without any major complications. In another study by Vogl et al., the authors included 30 patients and documented that percutaneous LITT of lung tumors allowed complete ablation of lung carcinomas or For LITT, an irrigated application system was developed that diffuses laser energy in a predefined volume and thus produces homogeneous energy dissipation at its tip. New applicator systems comprise a scattering dome applicator, a sheath system and a thermally stable protective catheter so that the LITT applicator remains sterile and can be flexibly positioned. metastases with a low complication rate [13] . A study by Diederich and Hosten showed that LITT and RFA were a safe and minimally invasive method for the treatment of pulmonary carcinoma and/or pulmonary metastasis [14] . Similar results were obtained in the study by Weigel et al. [15] . Hosten et al. conducted research in ten patients using a miniaturized applicator system in order to determine the effect of LITT treatment on pulmonary tumors [3] . They found that LITT treatment was a safe and acceptable procedure.
Conclusion
Surgery is the treatment of choice for primary or metastatic lung neoplasms. If surgical resection of the lesion is not possible, other treatment methods such as LITT, RFA or microwave ablation can be used to treat the pulmonary lesions (primary or metastatic tumors). LITT was first used as a palliative therapy of tumors but, during the years, it has become an acceptable choice of therapy against lung tumors because it has many clinical advantages such as high patient safety, minimally invasive technique, repeatability of treatment, outpatient therapy management, improved long-term survival and effective local tumor control. A high tendency of the malignant cells to spread into surrounding tissues limits the achievement of complete cure in many situations. Recurrence may occur after incomplete removal or incomplete ablation of the lesion(s), which is considered as another limiting parameter. The combination of surgery and neoadjuvant ablation treatment methods sometimes turns inoperable lesions into curative ones. Focused therapy makes it possible to destroy treated lesions and to preserve healthy lobes of the lung. LITT treatment offers better quality of life and symptomatic relief for the patients. We consider LITT to be a major treatment modality in the complex area of lung oncology. Treatment outcome is determined by appropriate patient selection, evaluation of the procedure before treatment, awareness of the limitations of the available therapeutic ablative tools, and knowledge of tumor characteristics and metastatic spread. In addition to other modalities, such as surgery, radiotherapy or chemotherapy, ablative therapies have a major role in lung tumor treatment. Koch et al.
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Summary. Laser-induced thermotherapy (LITT) is a valid alternative to surgery, radiotherapy or chemotherapy in the treatment of pulmonary lesions. LITT is a safe, noninvasive technique to improve outcome, with better local tumor control compared with surgery, increased survival rate and relief of clinical symptoms. LITT can be used for the treatment of lung tumors that are ≤3 cm in diameter and ≤3 lesions in number.
LITT procedures provide high patient safety, minimally invasive technique, outpatient therapy management, repeatability of treatment, improved long-term survival and effective local tumor control.
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